408 related articles for article (PubMed ID: 38288116)
21. A Review of Podocyte Biology.
Garg P
Am J Nephrol; 2018; 47 Suppl 1():3-13. PubMed ID: 29852492
[TBL] [Abstract][Full Text] [Related]
22. Targeting podocyte-associated diseases.
Leeuwis JW; Nguyen TQ; Dendooven A; Kok RJ; Goldschmeding R
Adv Drug Deliv Rev; 2010 Nov; 62(14):1325-36. PubMed ID: 20828590
[TBL] [Abstract][Full Text] [Related]
23. Glomerular Endothelium and its Impact on Glomerular Filtration Barrier in Diabetes: Are the Gaps Still Illusive?
Ndisang JF
Curr Med Chem; 2018; 25(13):1525-1529. PubMed ID: 28685678
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of podocyte injury and implications for diabetic nephropathy.
Barutta F; Bellini S; Gruden G
Clin Sci (Lond); 2022 Apr; 136(7):493-520. PubMed ID: 35415751
[TBL] [Abstract][Full Text] [Related]
25. Rethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic?
Marshall CB
Am J Physiol Renal Physiol; 2016 Nov; 311(5):F831-F843. PubMed ID: 27582102
[TBL] [Abstract][Full Text] [Related]
26. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
[TBL] [Abstract][Full Text] [Related]
27. Extensive podocyte loss triggers a rapid parietal epithelial cell response.
Hakroush S; Cebulla A; Schaldecker T; Behr D; Mundel P; Weins A
J Am Soc Nephrol; 2014 May; 25(5):927-38. PubMed ID: 24335975
[TBL] [Abstract][Full Text] [Related]
28. HIV-associated nephropathy: experimental models.
Avila-Casado C; Fortoul TI; Chugh SS
Contrib Nephrol; 2011; 169():270-285. PubMed ID: 21252526
[TBL] [Abstract][Full Text] [Related]
29. Targeting the podocyte cytoskeleton: from pathogenesis to therapy in proteinuric kidney disease.
Tian X; Ishibe S
Nephrol Dial Transplant; 2016 Oct; 31(10):1577-83. PubMed ID: 26968197
[TBL] [Abstract][Full Text] [Related]
30. Podocyte-Specific Deletion of Yes-Associated Protein Causes FSGS and Progressive Renal Failure.
Schwartzman M; Reginensi A; Wong JS; Basgen JM; Meliambro K; Nicholas SB; D'Agati V; McNeill H; Campbell KN
J Am Soc Nephrol; 2016 Jan; 27(1):216-26. PubMed ID: 26015453
[TBL] [Abstract][Full Text] [Related]
31. Glomerular endothelial cell-podocyte stresses and crosstalk in structurally normal kidney transplants.
Menon R; Otto EA; Berthier CC; Nair V; Farkash EA; Hodgin JB; Yang Y; Luo J; Woodside KJ; Zamani H; Norman SP; Wiggins RC; Kretzler M; Naik AS
Kidney Int; 2022 Apr; 101(4):779-792. PubMed ID: 34952098
[TBL] [Abstract][Full Text] [Related]
32. ADAM10-Mediated Ectodomain Shedding Is an Essential Driver of Podocyte Damage.
Sachs M; Wetzel S; Reichelt J; Sachs W; Schebsdat L; Zielinski S; Seipold L; Heintz L; Müller SA; Kretz O; Lindenmeyer M; Wiech T; Huber TB; Lüllmann-Rauch R; Lichtenthaler SF; Saftig P; Meyer-Schwesinger C
J Am Soc Nephrol; 2021 Jun; 32(6):1389-1408. PubMed ID: 33785583
[TBL] [Abstract][Full Text] [Related]
33. Podocyte-specific Transcription Factors: Could MafB Become a Therapeutic Target for Kidney Disease?
Morito N; Usui T; Ishibashi S; Yamagata K
Intern Med; 2023 Jan; 62(1):11-19. PubMed ID: 35249929
[TBL] [Abstract][Full Text] [Related]
34. Invagination and infolding of podocytes in glomerular basement membrane in the cases of primary membranous nephropathy.
Masuda Y; Mii A; Shimizu A; Fujita E; Aki K; Ishikawa K; Ishizaki M; Sato S; Hayama N; Iino Y; Katayama Y; Fukuda Y
Clin Exp Nephrol; 2008 Dec; 12(6):440-9. PubMed ID: 18998049
[TBL] [Abstract][Full Text] [Related]
35. OPN deficiency results in severe glomerulosclerosis in uninephrectomized mice.
Schordan S; Grisk O; Schordan E; Miehe B; Rumpel E; Endlich K; Giebel J; Endlich N
Am J Physiol Renal Physiol; 2013 Jun; 304(12):F1458-70. PubMed ID: 23552865
[TBL] [Abstract][Full Text] [Related]
36. Endothelin receptor-A mediates degradation of the glomerular endothelial surface layer via pathologic crosstalk between activated podocytes and glomerular endothelial cells.
Ebefors K; Wiener RJ; Yu L; Azeloglu EU; Yi Z; Jia F; Zhang W; Baron MH; He JC; Haraldsson B; Daehn I
Kidney Int; 2019 Oct; 96(4):957-970. PubMed ID: 31402170
[TBL] [Abstract][Full Text] [Related]
37. Podocytes regulate the glomerular basement membrane protein nephronectin by means of miR-378a-3p in glomerular diseases.
Müller-Deile J; Dannenberg J; Schroder P; Lin MH; Miner JH; Chen R; Bräsen JH; Thum T; Nyström J; Staggs LB; Haller H; Fiedler J; Lorenzen JM; Schiffer M
Kidney Int; 2017 Oct; 92(4):836-849. PubMed ID: 28476557
[TBL] [Abstract][Full Text] [Related]
38. Sirtuins as novel pharmacological targets in podocyte injury and related glomerular diseases.
Liu T; Yang L; Mao H; Ma F; Wang Y; Li S; Li P; Zhan Y
Biomed Pharmacother; 2022 Nov; 155():113620. PubMed ID: 36122519
[TBL] [Abstract][Full Text] [Related]
39. Wnt/β-catenin signalling and podocyte dysfunction in proteinuric kidney disease.
Zhou L; Liu Y
Nat Rev Nephrol; 2015 Sep; 11(9):535-45. PubMed ID: 26055352
[TBL] [Abstract][Full Text] [Related]
40. Research progress on exosomes in podocyte injury associated with diabetic kidney disease.
Li J; Zheng S; Ma C; Chen X; Li X; Li S; Wang P; Chen P; Wang Z; Li W; Liu Y
Front Endocrinol (Lausanne); 2023; 14():1129884. PubMed ID: 37020588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
